Correction to: British Journal of Pharmacology (2007) 151, 1061–1070. doi: 10.1038/sj.bjp.0707303
Since the online publication of the above paper, the authors have noticed an error in the labelling of Figure 4b. The corrected figure is shown below.
Figure 4.
Effects of R,S-AM1241 and its enantiomers, R-AM1241 and S-AM1241, on visceral pain and thermal hyperalgesia associated with chemical irritants. (a) Male CD-1 mice (25–30 g; n=10 per group) were pretreated with vehicle or compound (s.c.) 30 min before PPQ administration and tested 10 min post-administration. Data (mean±s.e.m.) are expressed as percent blockade relative to vehicle-treated mice. (b) Male SD rats (220–250 g; n=8 per group) received an intraplantar injection of 50 μl of saline or 2% carrageenan into the hindpaw, followed 2.5 h later by i.p. administration of vehicle, R,S-AM1241, R-AM1241 or S-AM1241. Data (mean±s.e.m.) are expressed as percent reversal relative to vehicle-treated rats. (c) Male SD rats (220–250 g; n=10 per group) received an intraplantar injection of 50 μl of saline or 2% carrageenan into the hindpaw, followed 2.5 h later by i.p. administration of either vehicle or 10 mg kg−1 S-AM1241 and either vehicle or 1 mg kg−1 AM630. Data (mean±s.e.m.) are expressed as paw withdrawal latencies; pre-carrageenan baseline data not shown. I.p., intraperitoneal; SD rat, Sprague–Dawley rat.